Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Latest Guidelines “Dropped” After Scandal Over EXCEL Results

The European Association for Cardio-Thoracic Surgery (EACTS) formally withdrew its support for the latest coronary revascularization guidelines following a BBC investigation suggesting that data from the EXCEL trial might have been manipulated.

Escándalo con los resultados del EXCEL que hicieron “caer” las últimas guías

The recommendations for left main coronary artery revascularization featured in the 2018 guidelines, which were written jointly with the European Society of Cardiology (ESC), were mainly based on the EXCEL trial.

That is why EACTS withdrew its support for its own guidelines after becoming aware, through a BBC investigation, of the fact that patients who underwent angioplasty experienced significantly more infarctions that those who underwent surgery. Between the publication of the 2018 guidelines and today, many patients may have received the wrong clinical advice from their cardiologists.


Read also: The EXCEL Authors’ Answer to the BBC Investigation.


David Taggart, MD, PhD (University of Oxford, England), lead investigator of the EXCEL surgical committee during the recruitment phase, was very critical of its results; he even requested that his name be removed from the New England Journal of Medicine paper in the 5-year follow-up. Who would refuse to be the author of a paper published in the most prestigious medicine journal in the world? Clearly, someone who suspected that the results were not right.

After the EXCEL trial was published in NEJM in 2016, the guidelines were updated in 2018 and coronary angioplasty received a class IA recommendation for patients with a low SYNTAX score (the same recommendation for surgery). For patients with left main lesions and intermediate and high SYNTAX scores, the recommendations were class IIA and III, respectively. Surgery remains a class IA recommendation, regardless of SYNTAX score.

At 3 years, the EXCEL trial showed no difference in the risk of death, infarction, or stroke between patients with left main disease and low-to-intermediate SYNTAX score treated with angioplasty and those treated with surgery. However, the BBC investigation reported that, according to the Third Universal Definition for infarction, the rate for this event was 80% higher in the angioplasty group than in the surgical group.


Read also: Mechanisms of Infarction in Coronary Arteries with Non-Significant Lesions.


The EXCEL results were absolutely crucial for the 2018 guidelines update; this is why such a controversy arose with the BBC investigation.

The rate of acute myocardial infarction as identified by the Third Universal Definition was listed as one of the secondary endpoints in the study protocol. However, for some reason, it was not reported in the NEJM paper.

Choosing a definition for infarction is more complex than it might appear, and the interventional committee and the surgical committee both agreed on the definition used on EXCEL as the primary endpoint (an unprecedented team effort for an angioplasty vs. surgery study). According to this definition, the results are similar between both revascularization strategies. Using the Third Universal Definition changes the results and there is no problem with that: the definition changes and so do results. The problem was the omission of these data in the article.

We expect formal explanations from the authors so as to clarify the situation in the next few days.

Original title: Surgeons withdraw support for heart disease advice.

Reference: Cohen D et al. BBC News.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...

Calcified Nodules and Their Treatment with Rotational Atherectomy

Calcified nodules (CN) represent one of the most complex phenotypes to treat in coronary intervention. They are mainly associated with the need for repeat...

Complex PCI: higher ischemic and bleeding risk in contemporary practice

Advances in pharmacological therapies, equipment, and devices have enabled percutaneous coronary interventions (PCI) to be performed in a growing number of patients with a...

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

SCAI 2026 | Deep vein arterialization as an alternative in patients with critical limb ischemia without conventional options

Critical limb ischemia (CLI) represents one of the most advanced stages of peripheral arterial disease (PAD). In a significant proportion of patients, distal anatomy,...

SCAI 2026 | Can an atrial fixation device prevent complications of transcatheter mitral valve replacement? Analysis of the AltaValve system

Transcatheter mitral valve replacement (TMVR) represents one of the most complex areas within structural interventions. Unlike TAVI, where valvular anatomy typically provides more predictable...

SCAI 2026 | SELUTION DeNovo subanalysis: Use of sirolimus-eluting balloon in acute coronary syndrome

Percutaneous coronary intervention (PCI) with drug-eluting stent (DES) implantation remains the predominant strategy in the setting of acute coronary syndrome (ACS). However, in recent...